Filter Results:
(4,071)
Show Results For
- All HBS Web
(4,071)
- People (9)
- News (1,041)
- Research (2,346)
- Events (5)
- Multimedia (63)
- Faculty Publications (1,182)
Show Results For
- All HBS Web
(4,071)
- People (9)
- News (1,041)
- Research (2,346)
- Events (5)
- Multimedia (63)
- Faculty Publications (1,182)
- Article
Why Do Firms Have 'Purpose'? The Firm's Role as a Carrier of Identity and Reputation
By: Rebecca Henderson and Eric Van den Steen
Why do so many firms publicly espouse a "purpose" beyond simple profit maximization? And why do so many managers and employees appear to care deeply about this purpose and to believe that it is critically important? In this paper we argue that the conventional answers... View Details
Henderson, Rebecca, and Eric Van den Steen. "Why Do Firms Have 'Purpose'? The Firm's Role as a Carrier of Identity and Reputation." American Economic Review: Papers and Proceedings 105, no. 5 (May 2015): 326–330.
- 18 May 2022
- Research & Ideas
Are Banks the ‘Bad Guys’? Overdraft Fees Are Crushing Low-Income Customers
shows. Despite scrutiny of overdraft fees during the financial crisis more than a decade ago, some banks still reorder checking account debits so that the largest amounts, rather than the earliest debits posted, are withdrawn first.... View Details
- January 2001 (Revised May 2003)
- Case
Novartis Pharma: The Business Unit Model
By: Srikant M. Datar, Carin-Isabel Knoop and Cate Reavis
In June 2000, Novartis reorganized its pharmaceutical business to form global business units in oncology, transplantation, ophthalmology, and mature products. The remaining primary care products continued to be managed within global functions (e.g., R&D and marketing).... View Details
Keywords: Restructuring; Recruitment; Product Marketing; Organizational Structure; Problems and Challenges; Health Industry; Pharmaceutical Industry
Datar, Srikant M., Carin-Isabel Knoop, and Cate Reavis. "Novartis Pharma: The Business Unit Model." Harvard Business School Case 101-030, January 2001. (Revised May 2003.)
- TeachingInterests
Financial Reporting and Control
Throughout their careers, business leaders are required to measure and evaluate their organization's economic performance, improve resource allocation and strategy implementation within their organizations, and build accountability for performance through effective... View Details
- 24 Jul 2000
- Research & Ideas
Value Maximization and Stakeholder Theory
"Every organization attempting to accomplish something has to ask and answer the following question," writes HBS professor Michael C. Jensen in the introduction to his recent working paper: "What are we trying to... View Details
Keywords: by Michael C. Jensen
- September–October 2020
- Article
Social-Impact Efforts That Create Real Value
By: George Serafeim
Until the mid-2010s few investors paid attention to environmental, social, and governance (ESG) data—information about companies’ carbon footprints, labor policies, board makeup, and so forth. Today the data is widely used by investors. How can organizations create... View Details
Keywords: Sustainability; Sustainability Management; ESG; ESG (Environmental, Social, Governance) Performance; ESG Disclosure; ESG Disclosure Metrics; ESG Ratings; ESG Reporting; Social Impact; Impact Measurement; Social Innovation; Purpose; Corporate Purpose; Corporate Social Responsibility; Strategy; Social Enterprise; Society; Accounting; Investment; Environmental Sustainability; Climate Change; Corporate Strategy; Mission and Purpose; Corporate Social Responsibility and Impact; Financial Services Industry; Chemical Industry; Technology Industry; Consumer Products Industry; Pharmaceutical Industry; North America; Europe; Japan; Australia
Serafeim, George. "Social-Impact Efforts That Create Real Value." Harvard Business Review 98, no. 5 (September–October 2020): 38–48.
- 31 Jan 2022
- Research & Ideas
Where Can Digital Transformation Take You? Insights from 1,700 Leaders
Customers demand more value and innovation than ever before, but they’re not always willing to pay more for that product or service. In fact, thanks to social media, dissatisfied customers can amplify their opinions about a company’s long support wait times or hold... View Details
- 24 Mar 2021
- News
Who will win the delivery app war?
- May 2014 (Revised January 2015)
- Case
Vaxess Technologies, Inc.
By: John A. Quelch and Margaret L. Rodriguez
In February 2014, Michael Schrader, chief executive of Vaxess Technologies, Inc., was assessing the startup health care company's 2014 marketing plan. On December 31st, 2013, Vaxess had obtained an exclusive license to a series of patents for a silk protein technology... View Details
Keywords: Vaccine; Cold Chain; Antigen; Temperature Controlled; Developing Markets; Immunization; Health Care and Treatment; Health Pandemics; Global Strategy; Supply Chain; Health; Health Industry; Medical Devices and Supplies Industry
Quelch, John A., and Margaret L. Rodriguez. "Vaxess Technologies, Inc." Harvard Business School Case 514-107, May 2014. (Revised January 2015.)
Anywhere Sikochi
Anywhere (Siko) Sikochi is a Berol Corporation Fellow and assistant professor in the Accounting and Management unit, where he teaches the Financial Reporting and Control course in the MBA required curriculum. He is a faculty affiliate to the Gender Initiative at HBS... View Details
- 30 Sep 2022
- Blog Post
Latina Women in Leadership: Jacqueline Burgos (MBA 2014)
Jacqueline Burgos (MBA 2014) grew up in Brooklyn, New York and received a BBA from Pace University’s Pforzheimer Honors College with a concentration in Accounting and minors in Economics and Latin American Studies. During her time at HBS... View Details
- 29 Oct 2015
- News
Options to Promote Competitive Generics Markets in the United States
- January 2011 (Revised January 2012)
- Supplement
The Case of the Unidentified Healthcare Companies2010 (CW)
By: Richard M.J. Bohmer, Ethan S Bernstein, Margarita Krivitski and Srinidhi Reddy
This case presents financial statements and selected rations for 14 unidentified healthcare organizations and asks that each set of financial information be matched with one of the following healthcare companies: a biotechnology firm, a community nursing company, a... View Details
- 2012
- Book
The Culture Cycle: How to Shape the Unseen Force That Transforms Performance
By: James Heskett
The contribution of culture to organizational performance is both substantial and quantifiable. This book presents the results of field research that demonstrates how an effective culture can account for up to half of the differential in performance between... View Details
Keywords: Customer Focus and Relationships; Learning; Framework; Policy; Retention; Books; Analytics and Data Science; Innovation and Invention; Management Practices and Processes; Organizational Culture; Performance Expectations; Research
Heskett, James. The Culture Cycle: How to Shape the Unseen Force That Transforms Performance. Upper Saddle River, NJ: FT Press, 2012.
- December 2012
- Background Note
Are Daily Deals Good for Merchants?
By: Sunil Gupta, Timothy Keiningham, Ray Weaver and Luke Williams
In the relatively short time since Groupon was founded, the response to "daily deals"—services that promote businesses by marketing deeply discounted, pre-paid vouchers to an online subscriber base—has by all accounts been spectacular. Our evaluation of daily deals is... View Details
Keywords: Marketing; Technology; Business Strategy; Digital; Marketing Strategy; Web Services Industry
Gupta, Sunil, Timothy Keiningham, Ray Weaver, and Luke Williams. "Are Daily Deals Good for Merchants?" Harvard Business School Background Note 513-059, December 2012.
- March 2020 (Revised August 2020)
- Case
Last Mile Health (A)
By: Brian Trelstad and V. Kasturi Rangan
As the Ebola outbreak threatens the fragile health system of Liberia, Raj Panjabi, the founder of Last Mile Health, faces a dilemma: should he expand beyond the organizaton's core mission to help the country build emergency health care capacity, or should he stick to... View Details
Keywords: Healthcare; Ebola; Nonprofit Organizations; Health Care and Treatment; Rural Scope; Health Pandemics; Growth and Development; Decisions; Health Industry; Africa
Trelstad, Brian, and V. Kasturi Rangan. "Last Mile Health (A)." Harvard Business School Case 320-027, March 2020. (Revised August 2020.)
- 25 Sep 2019
- News
The Economic Cost of Physician Burnout
- Research Summary
Fairness and Efficiency in Resource Allocation
In studying the relationship of fairness and efficiency, Professor Trichakis takes the novel approach of looking at varied industries for unifying factors, and he pays special attention to inequities by incorporating both quantitative work in social welfare and the... View Details
- 23 Sep 2015
- News